1448189-30-7

Basic information

• Product Name: (4-(4-methylthiazol-5-yl)phenyl)methanamine
• Synonyms: (4-(4-methylthiazol-5-yl)phenyl)methanamine;4-(4-Methylthiazol-5-yl)benzylamine;[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methanamine;4-(4-Methyl-5-thiazolyl)benzenemethanamine;(4-(4-methylthiazol-5-yl)phenyl)methanamine hydrochloride
• CAS NO: 1448189-30-7
• Molecular Formula: C₁₁H₁₂N₂S
• Molecular Weight: 204.3
• Mol File: 1448189-30-7.mol
• Article Data: 34

Chemical Properties

• Boiling Point: 343.0±30.0 °C(Predicted)
• Appearance: /
• Density: 1.176±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 9.12±0.10(Predicted)
• CAS DataBase Reference: (4-(4-methylthiazol-5-yl)phenyl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(4-methylthiazol-5-yl)phenyl)methanamine(1448189-30-7)
• EPA Substance Registry System: (4-(4-methylthiazol-5-yl)phenyl)methanamine(1448189-30-7)

Safety Data

• Hazardous Substances Data: 1448189-30-7(Hazardous Substances Data)

Usage

General Description

(4-(4-methylthiazol-5-yl)phenyl)methanamine is a chemical compound with a complex molecular structure. It contains a thiazole ring and a phenyl group, with a methyl group attached to the thiazole ring. The compound also contains an amine group, which is attached to the phenyl ring. This chemical may have various uses in different industries, such as pharmaceuticals, agrochemicals, and materials science, due to its unique molecular structure and potential for interactions with other compounds. Further research and analysis may be necessary to fully understand the properties and potential applications of this compound.

Upstream product

• 1448189-29-4 2-(trimethylsilyl)ethyl 4-(4-methylthiazol-5-yl)benzylcarbamate 
• 623-00-7 4-bromobenzenecarbonitrile 
• 122957-57-7 4-(4-methyl-1,3-thiazol-5-yl)benzonitrile 
• 3959-07-7 4-Bromobenzylamine 
• 26177-44-6 4-bromobenzylamine hydrochloride 
• 1448189-28-3 2-(trimethylsilyl)ethyl 4-bromobenzylcarbamate 
• 693-95-8 4-Methylthiazole 
• 68819-84-1 tert-butyl N-(4-bromobenzyl)carbamate 

Downstream Products

• 1448191-54-5 tert‐butyl (2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidine‐1‐carboxylate 
• 1448189-33-0 (2S,4R)-4-(tert-butoxy)-1-(2-(3-methylisoxazol-5-yl)acetyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1448189-45-4 (2S,4R)-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide 
• 1418120-86-1 C₂₅H₂₇N₃O₄S 
• 1418120-88-3 C₂₃H₂₂BrN₃O₃S 
• 1418120-94-1 (2S,4R)-4-hydroxy-1-(3-hydroxybenzoyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1418120-96-3 C₂₄H₂₆N₄O₃S 
• 1418120-92-9 C₂₄H₂₂N₄O₃S 
• 1418120-52-1 (2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1448186-82-0 (S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl acetate 
• 1448187-20-9 (2S,4R)-1-acetyl-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1448186-85-3 (2S,4R)-4-hydroxy-1-(3-hydroxy-2-methylbenzoyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1448187-01-6 (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)propanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 
• 1448189-47-6 tert-butyl N-[(2S)-1-[(2S,4R)-4-hydroxy-2-({[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamate 

Relevant articles and documents

MICROMOLECULAR COMPOUND SPECIFICALLYDEGRADING TAU PROTEIN, AND APPLICATION THEREOF

The present disclosure discloses a micromolecular compound specifically degrading tau protein, and an application thereof. The chemical structure of the micromolecular compound specifically degrading tau protein is TBM-L-ULM or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph or N-oxide thereof, TBM being a tau protein-binding moiety, L being a linking group, and ULM being a ubiquitin ligase-binding moiety, the tau protein-binding moiety and the ubiquitin ligase-binding moiety being connected by means of the linking group. The micromolecular compound specifically degrading tau protein may increase tau protein degradation in a cell, thereby decreasing tau protein content.

SMALL-MOLECULE INHIBITORS FOR THE Β-CATENIN/B-CELL LYMPHOMA 9 PROTEIN?PROTEIN INTERACTION

Disclosed are inhibitors for the β-catenin/B-cell lymphoma 9 interaction. The inhibitors are selective for β-catenin/B-cell lymphoma 9 over β-catenin/ E-cadherin PPI interaction. Methods of using the disclosed compounds to treat cancer are also disclosed.

Compound targeting ubiquitination degradation tyrosinase as well as preparation method and application thereof

A Tyr inhibitor kojic acid is covalently bound to a pomalidomide or VHL enzyme targeting ligand through a linkage chain to obtain a specific structure, and the preparation method is simple to operate and mild in condition. The generation of melanin is inhibited, the anti-melanin tumor effect is remarkable, and the safety period of vegetables and fruits can be remarkably prolonged. The compound targeted ubiquitination degradation tyrosinase provided by the invention has wide application prospects in medicine, food and cosmetics.